1. Home
  2. PMVP vs ASRT Comparison

PMVP vs ASRT Comparison

Compare PMVP & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMVP
  • ASRT
  • Stock Information
  • Founded
  • PMVP 2013
  • ASRT 1995
  • Country
  • PMVP United States
  • ASRT United States
  • Employees
  • PMVP N/A
  • ASRT N/A
  • Industry
  • PMVP Medicinal Chemicals and Botanical Products
  • ASRT Biotechnology: Pharmaceutical Preparations
  • Sector
  • PMVP Health Care
  • ASRT Health Care
  • Exchange
  • PMVP Nasdaq
  • ASRT Nasdaq
  • Market Cap
  • PMVP 85.5M
  • ASRT 85.1M
  • IPO Year
  • PMVP 2020
  • ASRT 1997
  • Fundamental
  • Price
  • PMVP $1.43
  • ASRT $0.80
  • Analyst Decision
  • PMVP Strong Buy
  • ASRT Strong Buy
  • Analyst Count
  • PMVP 3
  • ASRT 4
  • Target Price
  • PMVP $5.33
  • ASRT $3.19
  • AVG Volume (30 Days)
  • PMVP 158.0K
  • ASRT 357.9K
  • Earning Date
  • PMVP 02-27-2025
  • ASRT 03-10-2025
  • Dividend Yield
  • PMVP N/A
  • ASRT N/A
  • EPS Growth
  • PMVP N/A
  • ASRT N/A
  • EPS
  • PMVP N/A
  • ASRT N/A
  • Revenue
  • PMVP N/A
  • ASRT $125,763,000.00
  • Revenue This Year
  • PMVP N/A
  • ASRT N/A
  • Revenue Next Year
  • PMVP N/A
  • ASRT $1.84
  • P/E Ratio
  • PMVP N/A
  • ASRT N/A
  • Revenue Growth
  • PMVP N/A
  • ASRT N/A
  • 52 Week Low
  • PMVP $1.32
  • ASRT $0.73
  • 52 Week High
  • PMVP $2.26
  • ASRT $1.80
  • Technical
  • Relative Strength Index (RSI)
  • PMVP 47.66
  • ASRT 43.92
  • Support Level
  • PMVP $1.37
  • ASRT $0.78
  • Resistance Level
  • PMVP $1.46
  • ASRT $0.83
  • Average True Range (ATR)
  • PMVP 0.05
  • ASRT 0.03
  • MACD
  • PMVP 0.01
  • ASRT 0.00
  • Stochastic Oscillator
  • PMVP 78.57
  • ASRT 39.86

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: